HEADER CELL CYCLE 01-JUN-07 2JQI TITLE NMR STRUCTURE OF THE RAD53 FHA1 DOMAIN IN COMPLEX WITH A TITLE 2 PHOSPHOTHREONIEN PEPTIDE DERIVED FROM RAD53 SCD1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE RAD53; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: SERINE-PROTEIN KINASE 1; COMPND 5 EC: 2.7.11.1; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: SERINE/THREONINE-PROTEIN KINASE RAD53; COMPND 9 CHAIN: B; COMPND 10 SYNONYM: SERINE-PROTEIN KINASE 1; COMPND 11 EC: 2.7.11.1; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SACCHAROMYCES CEREVISIAE; SOURCE 3 ORGANISM_COMMON: YEAST; SOURCE 4 GENE: RAD53, MEC2, SAD1, SPK1; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PGEX-4T; SOURCE 9 MOL_ID: 2; SOURCE 10 SYNTHETIC: YES KEYWDS PROTEIN/PHOSPHOPEPTIDE, CELL CYCLE EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR C.YUAN,A.MAHAJAN,M.TSAI REVDAT 5 20-DEC-23 2JQI 1 REMARK REVDAT 4 09-MAR-22 2JQI 1 REMARK SEQADV LINK REVDAT 3 24-FEB-09 2JQI 1 VERSN REVDAT 2 01-JUL-08 2JQI 1 JRNL REVDAT 1 24-JUN-08 2JQI 0 JRNL AUTH H.LEE,C.YUAN,A.HAMMET,A.MAHAJAN,E.S.CHEN,M.R.WU,M.I.SU, JRNL AUTH 2 J.HEIERHORST,M.D.TSAI JRNL TITL DIPHOSPHOTHREONINE-SPECIFIC INTERACTION BETWEEN AN SQ/TQ JRNL TITL 2 CLUSTER AND AN FHA DOMAIN IN THE RAD53-DUN1 KINASE CASCADE. JRNL REF MOL.CELL V. 30 767 2008 JRNL REFN ISSN 1097-2765 JRNL PMID 18570878 JRNL DOI 10.1016/J.MOLCEL.2008.05.013 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1, CNS 1.1 REMARK 3 AUTHORS : BRUNGER, A.T. ET AL. (CNS), BRUNGER, A.T. ET AL. REMARK 3 (CNS) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2JQI COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 04-JUN-07. REMARK 100 THE DEPOSITION ID IS D_1000100162. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 293 REMARK 210 PH : 6.5 REMARK 210 IONIC STRENGTH : 10 MM SODIUM PHOSPHATE REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 0.5 MM [U-13C; U-15N] PROTEIN, REMARK 210 0.8 MM PEPTIDE, 10 MM SODIUM REMARK 210 PHOSPHATE, 1 MM DTT, 1 MM EDTA, REMARK 210 90% H2O/10% D2O; 0.5 MM [U-13C; REMARK 210 U-15N] PROTEIN, 0.8 MM PEPTIDE, REMARK 210 10 MM SODIUM PHOSPHATE, 1 MM DTT, REMARK 210 1 MM EDTA, 100% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 3D 1H-13C NOESY; 3D 13C/15N REMARK 210 -FILTERED (F1), 13C-EDITED (F3) REMARK 210 NOESY; 3D 13C-EDITED (F1), 13C/ REMARK 210 15N-FILTERED (F3) NOESY; 2D 13C/ REMARK 210 15N-FILTERED (F1,F2) NOESY; 2D REMARK 210 13C/15N-FILTERED (F1,F2) TOCSY; REMARK 210 2D 13C/15N-FILTERED (F1,F2) COSY REMARK 210 SPECTROMETER FIELD STRENGTH : 800 MHZ; 600 MHZ REMARK 210 SPECTROMETER MODEL : DRX; DMX REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NMRPIPE, NMRVIEW REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH ACCEPTABLE REMARK 210 COVALENT GEOMETRY,STRUCTURES REMARK 210 WITH THE LEAST RESTRAINT REMARK 210 VIOLATIONS,STRUCTURES WITH THE REMARK 210 LOWEST ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 H TRP A 66 O ILE A 91 1.53 REMARK 500 H PHE A 68 O PHE A 89 1.59 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 THR A 15 -61.08 -128.73 REMARK 500 1 ASN A 31 38.53 178.60 REMARK 500 1 VAL A 33 -60.00 -92.32 REMARK 500 1 GLN A 42 -42.92 -146.32 REMARK 500 1 SER A 61 -85.00 61.19 REMARK 500 1 LYS A 63 -68.53 -106.45 REMARK 500 1 ASN A 80 54.34 178.78 REMARK 500 1 GLU A 95 -165.32 56.05 REMARK 500 1 ASN A 119 35.02 34.63 REMARK 500 1 ASP A 128 170.53 -52.14 REMARK 500 1 ASN A 158 92.28 42.45 REMARK 500 1 ILE B 4 161.55 52.47 REMARK 500 2 THR A 15 -55.42 -158.27 REMARK 500 2 ASN A 31 37.81 179.62 REMARK 500 2 VAL A 33 -60.76 -92.26 REMARK 500 2 GLN A 42 -47.35 -161.72 REMARK 500 2 GLU A 58 99.76 -62.82 REMARK 500 2 ARG A 60 95.87 64.82 REMARK 500 2 SER A 61 -168.41 -179.32 REMARK 500 2 LYS A 63 -76.64 61.20 REMARK 500 2 GLU A 95 -67.19 69.11 REMARK 500 2 ASP A 96 -47.19 -140.87 REMARK 500 2 ASN A 98 179.80 -59.74 REMARK 500 2 ILE A 104 39.08 -143.84 REMARK 500 2 ASN A 119 35.04 35.43 REMARK 500 2 ASP A 128 174.37 -55.23 REMARK 500 2 ASN A 158 -172.42 44.85 REMARK 500 2 ASP A 161 -48.20 -134.12 REMARK 500 2 ILE B 4 157.46 52.04 REMARK 500 2 THR B 8 111.68 -163.49 REMARK 500 2 GLN B 9 97.25 58.88 REMARK 500 3 GLN A 25 81.26 59.67 REMARK 500 3 ASN A 31 38.56 177.11 REMARK 500 3 VAL A 33 -61.58 -92.75 REMARK 500 3 GLN A 42 -41.00 -147.95 REMARK 500 3 ASN A 80 89.43 -69.93 REMARK 500 3 GLU A 95 -80.39 62.38 REMARK 500 3 ASP A 96 42.93 -169.39 REMARK 500 3 ILE A 104 38.18 -149.22 REMARK 500 3 ASN A 119 34.72 35.02 REMARK 500 3 ASN A 158 65.32 -115.61 REMARK 500 3 PRO B 7 -168.70 -71.04 REMARK 500 3 SER B 11 79.98 60.85 REMARK 500 4 ASN A 31 37.97 178.80 REMARK 500 4 VAL A 33 -60.87 -93.10 REMARK 500 4 GLN A 42 -44.29 -146.29 REMARK 500 4 ARG A 60 176.43 -54.09 REMARK 500 4 LYS A 63 -68.45 -127.92 REMARK 500 4 ASN A 80 84.27 -67.32 REMARK 500 4 GLU A 95 90.47 63.18 REMARK 500 REMARK 500 THIS ENTRY HAS 288 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2JQJ RELATED DB: PDB REMARK 900 RELATED ID: 2JQL RELATED DB: PDB DBREF 2JQI A 14 164 UNP P22216 RAD53_YEAST 14 164 DBREF 2JQI B 3 12 UNP P22216 RAD53_YEAST 3 12 SEQADV 2JQI TPO B 5 UNP P22216 THR 5 MODIFIED RESIDUE SEQRES 1 A 151 ALA THR GLN ARG PHE LEU ILE GLU LYS PHE SER GLN GLU SEQRES 2 A 151 GLN ILE GLY GLU ASN ILE VAL CYS ARG VAL ILE CYS THR SEQRES 3 A 151 THR GLY GLN ILE PRO ILE ARG ASP LEU SER ALA ASP ILE SEQRES 4 A 151 SER GLN VAL LEU LYS GLU LYS ARG SER ILE LYS LYS VAL SEQRES 5 A 151 TRP THR PHE GLY ARG ASN PRO ALA CYS ASP TYR HIS LEU SEQRES 6 A 151 GLY ASN ILE SER ARG LEU SER ASN LYS HIS PHE GLN ILE SEQRES 7 A 151 LEU LEU GLY GLU ASP GLY ASN LEU LEU LEU ASN ASP ILE SEQRES 8 A 151 SER THR ASN GLY THR TRP LEU ASN GLY GLN LYS VAL GLU SEQRES 9 A 151 LYS ASN SER ASN GLN LEU LEU SER GLN GLY ASP GLU ILE SEQRES 10 A 151 THR VAL GLY VAL GLY VAL GLU SER ASP ILE LEU SER LEU SEQRES 11 A 151 VAL ILE PHE ILE ASN ASP LYS PHE LYS GLN CYS LEU GLU SEQRES 12 A 151 GLN ASN LYS VAL ASP ARG ILE ARG SEQRES 1 B 10 ASN ILE TPO GLN PRO THR GLN GLN SER THR MODRES 2JQI TPO B 5 THR PHOSPHOTHREONINE HET TPO B 5 17 HETNAM TPO PHOSPHOTHREONINE HETSYN TPO PHOSPHONOTHREONINE FORMUL 2 TPO C4 H10 N O6 P HELIX 1 1 THR A 15 GLN A 25 1 11 HELIX 2 2 ASP A 51 GLU A 58 1 8 HELIX 3 3 ASN A 148 ASN A 158 1 11 SHEET 1 A 6 ARG A 46 SER A 49 0 SHEET 2 A 6 ILE A 32 CYS A 38 -1 N VAL A 33 O LEU A 48 SHEET 3 A 6 LEU A 141 ILE A 147 -1 O PHE A 146 N ARG A 35 SHEET 4 A 6 GLU A 129 VAL A 132 -1 N VAL A 132 O LEU A 141 SHEET 5 A 6 THR A 109 LEU A 111 -1 N TRP A 110 O THR A 131 SHEET 6 A 6 GLN A 114 LYS A 115 -1 O GLN A 114 N LEU A 111 SHEET 1 B 5 TYR A 76 HIS A 77 0 SHEET 2 B 5 LYS A 64 GLY A 69 1 N GLY A 69 O TYR A 76 SHEET 3 B 5 PHE A 89 GLY A 94 -1 O PHE A 89 N PHE A 68 SHEET 4 B 5 ASN A 98 ASP A 103 -1 O ASN A 102 N GLN A 90 SHEET 5 B 5 ASN A 121 LEU A 123 -1 O GLN A 122 N LEU A 101 LINK C ILE B 4 N TPO B 5 1555 1555 1.33 LINK C TPO B 5 N GLN B 6 1555 1555 1.33 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1